These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5777 related articles for article (PubMed ID: 23872180)
1. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780 [TBL] [Abstract][Full Text] [Related]
3. Carbon nanotubes for delivery of small molecule drugs. Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402 [TBL] [Abstract][Full Text] [Related]
4. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
5. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers. Boakye CH; Patel K; Singh M Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414 [TBL] [Abstract][Full Text] [Related]
6. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Kim HK; Davaa E; Myung CS; Park JS Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025 [TBL] [Abstract][Full Text] [Related]
7. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids. Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914 [TBL] [Abstract][Full Text] [Related]
8. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells. Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854 [TBL] [Abstract][Full Text] [Related]
10. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems. Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365 [TBL] [Abstract][Full Text] [Related]
11. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes. Li WM; Xue L; Mayer LD; Bally MB Biochim Biophys Acta; 2001 Aug; 1513(2):193-206. PubMed ID: 11470091 [TBL] [Abstract][Full Text] [Related]
12. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245 [TBL] [Abstract][Full Text] [Related]
14. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
15. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
16. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA. Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226 [TBL] [Abstract][Full Text] [Related]
18. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149 [TBL] [Abstract][Full Text] [Related]
19. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof. Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189 [TBL] [Abstract][Full Text] [Related]
20. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery. Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]